These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29506222)

  • 1. Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults.
    Napoli N; Strollo R; Defeudis G; Leto G; Moretti C; Zampetti S; D'Onofrio L; Campagna G; Palermo A; Greto V; Manfrini S; Hawa MI; Leslie RD; Pozzilli P; Buzzetti R;
    J Clin Endocrinol Metab; 2018 May; 103(5):1921-1928. PubMed ID: 29506222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
    Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
    Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
    Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
    van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
    J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA).
    Hjort R; Alfredsson L; Andersson T; Carlsson PO; Grill V; Groop L; Martinell M; Rasouli B; Storm P; Tuomi T; Carlsson S
    Diabetes Metab; 2017 Dec; 43(6):536-542. PubMed ID: 28669512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial.
    Strollo R; Soare A; Manon Khazrai Y; Di Mauro A; Palermo A; Del Toro R; Fallucca S; Giovanna Belluomo M; Dugo L; Pianesi M; Pozzilli P; Napoli N
    Endocrine; 2017 Jun; 56(3):667-674. PubMed ID: 27888435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density spectrum in individuals with type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes.
    Hu Y; Li X; Yan X; Huang G; Dai R; Zhou Z
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3390. PubMed ID: 32748546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus.
    Yousefzadeh G; Gozashti M; Najafipour H; Gholamhosseinian NA; Bahramnejad A; Shokouhi M
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S52-5. PubMed ID: 27094870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
    Gennari L; Merlotti D; Valenti R; Ceccarelli E; Ruvio M; Pietrini MG; Capodarca C; Franci MB; Campagna MS; Calabrò A; Cataldo D; Stolakis K; Dotta F; Nuti R
    J Clin Endocrinol Metab; 2012 May; 97(5):1737-44. PubMed ID: 22399511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic volume is reduced in patients with latent autoimmune diabetes in adults.
    Lu J; Hou X; Pang C; Zhang L; Hu C; Zhao J; Bao Y; Jia W
    Diabetes Metab Res Rev; 2016 Nov; 32(8):858-866. PubMed ID: 27037998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
    Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
    Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a distinct phenotype of elderly latent autoimmune diabetes in adults: LADA China Study 8.
    Niu X; Luo S; Li X; Xie Z; Xiang Y; Huang G; Lin J; Yang L; Liu Z; Wang X; Leslie RD; Zhou Z
    Diabetes Metab Res Rev; 2019 Jan; 35(1):e3068. PubMed ID: 30160000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestation and islet β-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes.
    Liang H; Cheng Y; Tang W; Cui Q; Yuan J; Huang G; Yang L; Zhou Z
    Acta Diabetol; 2019 Nov; 56(11):1225-1230. PubMed ID: 31367990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower mortality and cardiovascular event rates in patients with Latent Autoimmune Diabetes In Adults (LADA) as compared with type 2 diabetes and insulin deficient diabetes: A cohort study of 4368 patients.
    Wod M; Thomsen RW; Pedersen L; Yderstraede KB; Beck-Nielsen H; Højlund K
    Diabetes Res Clin Pract; 2018 May; 139():107-113. PubMed ID: 29518492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.
    Buzzetti R; Tuomi T; Mauricio D; Pietropaolo M; Zhou Z; Pozzilli P; Leslie RD
    Diabetes; 2020 Oct; 69(10):2037-2047. PubMed ID: 32847960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).
    Maddaloni E; Coleman RL; Pozzilli P; Holman RR
    Diabetes Obes Metab; 2019 Sep; 21(9):2115-2122. PubMed ID: 31099472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent Autoimmune Diabetes in Adults in North Indian Region: Assessment of β-Cell Function, Metabolic and Immunological Features.
    Kumar A; de Leiva A
    Metab Syndr Relat Disord; 2017 Dec; 15(10):494-499. PubMed ID: 29040050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover.
    Yavropoulou MP; van Lierop AH; Hamdy NA; Rizzoli R; Papapoulos SE
    Bone; 2012 Jul; 51(1):153-7. PubMed ID: 22579776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.